Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Login and Edit functionaility are currrently unavailable.
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.
Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine.
Discontinuation reactions following sertraline.
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsed.
Increase in work productivity of depressed individuals with improvement in depressive symptom severity.